E-Submission Process Will Pare EMA Response Time on Trial Data Requests

Written on:October 8, 2013
Comments are closed

The European Medicines Agency expects to respond more expeditiously to public requests for clinical trial data, thanks in part to newly required electronic marketing authorization applications.

Source: International Pharmaceutical Regulatory Monitor


Sorry, the comment form is closed at this time.